TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
109.97
+4.37 (4.14%)
At close: Jul 23, 2025, 4:00 PM
110.40
+0.43 (0.39%)
After-hours: Jul 23, 2025, 7:56 PM EDT

Company Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.

Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers.

The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity.

The company was founded in 1998 and is headquartered in Andover, Massachusetts.

TransMedics Group, Inc.
TransMedics Group logo
CountryUnited States
Founded1998
IPO DateMay 2, 2019
IndustryMedical Devices
SectorHealthcare
Employees728
CEOWaleed Hassanein

Contact Details

Address:
200 Minuteman Road, Suite 302
Andover, Massachusetts 01810
United States
Phone978 552 0900
Websitetransmedics.com

Stock Details

Ticker SymbolTMDX
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$16.00
CIK Code0001756262
CUSIP Number89377M109
ISIN NumberUS89377M1099
SIC Code3845

Key Executives

NamePosition
Dr. Waleed H. Hassanein M.D.Founder, President, Chief Executive Officer and Director
Gerardo HernandezChief Financial Officer and Treasurer
Nicholas CorcoranSenior Vice President of Supply Chain and Operations
Anil RanganathSenior Vice President, General Counsel and Corporate Secretary
Dr. Tamer I. Khayal M.D.Chief Commercial Officer
Miriam C. Provost Ph.D.Vice President of Global Regulatory Affairs

Latest SEC Filings

DateTypeTitle
Jul 18, 2025SCHEDULE 13G/AFiling
May 30, 2025SDForm - SD
May 27, 2025144Filing
May 23, 2025144Filing
May 23, 20258-KCurrent Report
May 12, 2025SCHEDULE 13G/AFiling
May 9, 2025144Filing
May 8, 202510-QQuarterly Report
May 8, 20258-KCurrent Report
Apr 10, 2025ARSFiling